Search research articles
Contact Us
Filters
Showing results (41-50 of 102) with videos related to
Page
of 11
Sort By:
International Journal of Cancer
|
May 15, 1978
Relationship between Epstein-Barr virus (EBV)-production and the loss of the EBV receptor/complement receptor complex in a series of sublines derived from the same original Burkitt's lymphoma
G Klein, E Yefenof, K Falk, et al.
Bibliotheca Haematologica
|
October 1, 1975
Epstein-Barr virus (EBV)-determined characteristics in lymphoid cells
E Klein, H Neumann, M Steintz, et al.
Leukemia Research
|
January 1, 1979
Burkitt's lymphoma cells: membrane properties and surface morphology as seen by scanning electron microscopy
A Polliack, E Yefenof, H Gamliel, et al.
Intervirology
|
January 1, 1978
Inhibition of DNA metabolism in human B lymphocytes by a substrain of Epstein-Barr virus (P3HR-1): a method for virus quantitation
M Steinitz, T Bakács, E Yefenof, et al.
Journal of Clinical & Laboratory Immunology
|
February 1, 1988
Comparison of monocyte and complement mediated haemolysis of human A1 erythrocytes: the relationship between antibody, target and effector concentrations in the induction of lysis
T Bakács, K Tótpál, G Ringwald, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1995
Cholecystokinin-octapeptide (CCK-OP) and substance P (SP) influence immune response to cholera toxin in live animals
S Jarrah, M Eran, S Freier, et al.
European Journal of Immunology
|
July 1, 1992
Expression of the complement regulatory proteins CD21, CD55 and CD59 on Burkitt lymphoma lines: their role in sensitivity to human serum-mediated lysis
M Kuraya, E Yefenof, G Klein, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 24, 1998
Complement receptor 3 of macrophages is associated with galectin-1-like protein
O Avni, Z Pur, E Yefenof, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 15, 1992
Treatment of premalignancy: prevention of lymphoma in radiation leukemia virus-inoculated mice by cyclosporin A and immunotoxin
E Yefenof, G Abboud, S Epszteyn, et al.
International Journal of Cancer
|
February 1, 1992
Induction of IL-4 secretion by the radiation leukemia virus (RadLV): role in autocrine growth stimulation of RadLV infected pre-leukemic cells
E Yefenof, C Ela, M Kotler, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 102) with videos related to
Sort By:
Page
of 11
International Journal of Cancer
|
May 15, 1978
Relationship between Epstein-Barr virus (EBV)-production and the loss of the EBV receptor/complement receptor complex in a series of sublines derived from the same original Burkitt's lymphoma
G Klein, E Yefenof, K Falk, et al.
Bibliotheca Haematologica
|
October 1, 1975
Epstein-Barr virus (EBV)-determined characteristics in lymphoid cells
E Klein, H Neumann, M Steintz, et al.
Leukemia Research
|
January 1, 1979
Burkitt's lymphoma cells: membrane properties and surface morphology as seen by scanning electron microscopy
A Polliack, E Yefenof, H Gamliel, et al.
Intervirology
|
January 1, 1978
Inhibition of DNA metabolism in human B lymphocytes by a substrain of Epstein-Barr virus (P3HR-1): a method for virus quantitation
M Steinitz, T Bakács, E Yefenof, et al.
Journal of Clinical & Laboratory Immunology
|
February 1, 1988
Comparison of monocyte and complement mediated haemolysis of human A1 erythrocytes: the relationship between antibody, target and effector concentrations in the induction of lysis
T Bakács, K Tótpál, G Ringwald, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1995
Cholecystokinin-octapeptide (CCK-OP) and substance P (SP) influence immune response to cholera toxin in live animals
S Jarrah, M Eran, S Freier, et al.
European Journal of Immunology
|
July 1, 1992
Expression of the complement regulatory proteins CD21, CD55 and CD59 on Burkitt lymphoma lines: their role in sensitivity to human serum-mediated lysis
M Kuraya, E Yefenof, G Klein, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 24, 1998
Complement receptor 3 of macrophages is associated with galectin-1-like protein
O Avni, Z Pur, E Yefenof, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 15, 1992
Treatment of premalignancy: prevention of lymphoma in radiation leukemia virus-inoculated mice by cyclosporin A and immunotoxin
E Yefenof, G Abboud, S Epszteyn, et al.
International Journal of Cancer
|
February 1, 1992
Induction of IL-4 secretion by the radiation leukemia virus (RadLV): role in autocrine growth stimulation of RadLV infected pre-leukemic cells
E Yefenof, C Ela, M Kotler, et al.
Page
of 11